Investment Analysts’ Updated EPS Estimates for August 5th (ACIU, AGNT, AME, AMGN, BCC, DD, EXPD, GPOR, TMDX, ULS)

Investment Analysts’ updated eps estimates for Wednesday, August 5th:

AC Immune (NASDAQ:ACIU) had its buy rating reiterated by analysts at BTIG Research. They currently have a $8.00 target price on the stock.

Exp World (NASDAQ:AGNT) had its price target cut by DA Davidson from $6.50 to $4.75. They currently have a neutral rating on the stock.

AMETEK (NYSE:AME) had its price target increased by DA Davidson from $265.00 to $285.00. They currently have a buy rating on the stock.

Amgen (NASDAQ:AMGN) had its price target increased by UBS Group AG from $420.00 to $440.00. The firm currently has a buy rating on the stock.

Boise Cascade (NYSE:BCC) had its price target increased by DA Davidson from $92.00 to $99.00. They currently have a buy rating on the stock.

DuPont de Nemours (NYSE:DD) had its price target increased by UBS Group AG from $175.00 to $178.00. The firm currently has a buy rating on the stock.

Expeditors International of Washington (NASDAQ:EXPD) had its price target increased by UBS Group AG from $191.00 to $210.00. The firm currently has a buy rating on the stock.

Gulfport Energy (NYSE:GPOR) had its target price lowered by UBS Group AG from $223.00 to $214.00. The firm currently has a buy rating on the stock.

TransMedics Group (NASDAQ:TMDX) had its target price reduced by UBS Group AG from $80.00 to $77.00. They currently have a neutral rating on the stock.

UL Solutions (NYSE:ULS) had its target price cut by UBS Group AG from $110.00 to $96.00. UBS Group AG currently has a buy rating on the stock.

TeraWulf (NASDAQ:WULF) had its buy rating reiterated by analysts at Chardan Capital. They currently have a $32.00 target price on the stock.

Receive News & Ratings for AC Immune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AC Immune and related companies with MarketBeat.com's FREE daily email newsletter.